Programmed cell death 1 (PD‐1)/PD‐ligand 1(PD‐L1) inhibitors‐related pneumonitis in patients with advanced non–small cell lung cancer

Asia-Pacific Journal of Clinical Oncology ◽

10.1111/ajco.13380 ◽

2020 ◽

Vol 16 (6) ◽

pp. 299-304

Author(s):

Yuxin Sun ◽

Chi Shao ◽

Shan Li ◽

Yan Xu ◽

Kai Xu ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text

Association of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort

Annals of Oncology ◽

10.1093/annonc/mdx390.002 ◽

2017 ◽

Vol 28 ◽

pp. v573-v574

Author(s):

K.M. Kerr ◽

E. Thunnissen ◽

U. Dafni ◽

A. Soltermann ◽

S. Finn ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Molecular Alterations ◽

Programmed Cell Death 1 ◽

Download Full-text

Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer

Oncology Reports ◽

10.3892/or.2017.5894 ◽

2017 ◽

Vol 38 (4) ◽

pp. 2277-2284 ◽

Author(s):

Soichiro Funaki ◽

Yasushi Shintani ◽

Tomohiro Kawamura ◽

Ryu Kanzaki ◽

Masato Minami ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Epithelial Mesenchymal Transition ◽

Small Cell Lung ◽

Mesenchymal Transition ◽

Programmed Cell Death 1

Download Full-text

Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression ≥50%

Annals of Oncology ◽

10.1016/j.annonc.2019.11.015 ◽

2020 ◽

Vol 31 (3) ◽

pp. 404-411 ◽

Author(s):

J.F. Gainor ◽

H. Rizvi ◽

E. Jimenez Aguilar ◽

F. Skoulidis ◽

B.Y. Yeap ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Activity ◽

Small Cell Lung ◽

Programmed Cell Death 1 ◽

Download Full-text

Programmed cell death-1/Programmed cell death ligand-1(PD-1/PD-L1) inhibitors, heralding a new era of immunotherapy in the management of advanced Non-Small Cell Lung Cancer (NSCLC)

Cancer Treatment and Research Communications ◽

10.1016/j.ctarc.2017.05.002 ◽

2017 ◽

Vol 12 ◽

pp. 6-13 ◽

Author(s):

Foluso Ogunleye ◽

LeAnn Blankenship ◽

Vanessa Millisor ◽

Joseph Anderson ◽

Ishmael Jaiyesimi

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

New Era ◽

Programmed Cell Death 1

Download Full-text

Non-small Cell Lung Cancer Treated by an Anti-programmed Cell Death-1 Antibody without a Flare-up of Preexisting Granulomatosis with Polyangiitis

Internal Medicine ◽

10.2169/internalmedicine.3018-19 ◽

2019 ◽

Vol 58 (21) ◽

pp. 3129-3132 ◽

Author(s):

Takahiro Yamada ◽

Takeshi Masuda ◽

Kakuhiro Yamaguchi ◽

Shinjiro Sakamoto ◽

Yasushi Horimasu ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Granulomatosis With Polyangiitis ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text

Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer

European Journal of Cancer ◽

10.1016/j.ejca.2021.11.011 ◽

2022 ◽

Vol 161 ◽

pp. 44-54

Author(s):

Shinichiro Suzuki ◽

Koji Haratani ◽

Hidetoshi Hayashi ◽

Yasutaka Chiba ◽

Junko Tanizaki ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Tumour Burden ◽

Small Cell Lung ◽

Programmed Cell Death 1 ◽

Treatment Naïve

Download Full-text

Blood-borne cytokines for predicting clinical benefits and immune-related adverse events in advanced non-small cell lung cancer treated with anti- programmed cell death 1 inhibitors

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.007 ◽

2021 ◽

Author(s):

Jun Oyanagi ◽

Yasuhiro Koh ◽

Koichi Sato ◽

Shunsuke Teraoka ◽

Nahomi Tokudome ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Adverse Events ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell Lung ◽

Programmed Cell Death 1 ◽

Clinical Benefits

Download Full-text

Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer

Cancer Science ◽

10.1111/cas.14605 ◽

2020 ◽

Vol 111 (12) ◽

pp. 4442-4452

Author(s):

Yusuke Kagawa ◽

Hiromi Furuta ◽

Takehiro Uemura ◽

Naohiro Watanabe ◽

Junichi Shimizu ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Local Therapy ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text

1055P Updated results of subcutaneous (SC) anti-programmed cell death 1 (PD-1) receptor antibody PF-06801591 for locally advanced or metastatic non-small cell lung cancer (NSCLC) or urothelial carcinoma (UC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1175 ◽

2020 ◽

Vol 31 ◽

pp. S721

Author(s):

B.C. Chul Cho ◽

K.D. Penkov ◽

I. Bondarenko ◽

A. Kurochkin ◽

J. Pikiel ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Urothelial Carcinoma ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti‐Programmed Cell Death 1 Monotherapy for Advanced Non‐Small Cell Lung Cancer

The Oncologist ◽

10.1634/theoncologist.2019-0550 ◽

2019 ◽

Vol 25 (3) ◽

Author(s):

Mari Aso ◽

Yukihiro Toi ◽

Jun Sugisaka ◽

Tomoiki Aiba ◽

Sachiko Kawana ◽

...

Keyword(s):

Lung Cancer ◽

Programmed Cell Death ◽

Small Cell Lung Cancer ◽

Skin Reaction ◽

Cell Lung Cancer ◽

Clinical Benefit ◽

Small Cell Lung ◽

Programmed Cell Death 1

Download Full-text